• Farming accounts for over 20% of Nigeria’s GDP, yet most of the nation’s farmers live well below the poverty line due to the mechanics of the regional agricultural economy
• Tingo has sought to eliminate the market’s friction, providing farmers and agricultural cooperatives with digital access to a network of agricultural services, agents, and end purchasers
• The company operates a market leading Agri-Fintech through four key business pillars – mobile phone leasing, mobile voice and data services, the Nwassa Marketplace Platform and Tingo Pay

Farming accounts for over 20% of Nigeria’s GDP, with the nation’s farmers toiling endlessly to produce a range of crops, including palm oil, cocoa beans, maize, sorghum, nuts, rice, and soybeans. Nevertheless, the state of the Nigerian agricultural industry is underperforming; over 88 percent of Nigerian farms are ‘smallholders’, toiling on less than five acres of land. In fact, a recent study found that nearly 72 percent of Nigerian smallholder farms lived on less than $1.90 per day, with most living well below the poverty line. Tingo (OTCQB: IWBB), an Agri-Fintech company focused on foundation-level agriculture and related financial services in Africa, have sought to address this problem with a vision to build a digitally inclusive ecosystems which promotes financial inclusion and delivers disruptive micro-finance solutions, empowers societies, and produces social upliftment in rural communities. Tingo has centred their business model around four core business pillars, namely – mobile phone leasing, mobile voice and data services, the Nwassa Marketplace Platform and Tingo Pay. In effect, the vertically integrated business model enables Nigeria and the wider African continent’s farmers to procure a Tingo-manufactured handset, using Tingo’s mobile data and voice services. Farmers can then access the Nwassa platform, Tingo’s proprietary agritech marketplace which provides the continent’s farmers with access to domestic and global markets to secure more competitive pricing for their crops. Since its formation almost two decades ago, Tingo has seen its operations expand at a break-neck pace in the past five years. The company opened two mobile handset manufacturing plants, distributing almost 30 million mobile handsets since 2014 and remains committed to upgrading the devices of its installed customer base every three years. Moreover, and through their competitive pricing policies, Tingo’s handset customers spread their purchase payments over 36 months, thereby increasing the company’s products’ affordability which leads to incredible customer retention. In addition to the near 30 million mobile handsets, it has sold to date. The Tingo Mobile Network also boasts over 9.3 million mobile subscribers as of end-2020, with the company confident that the number will swell as its operations see their geographic scope broaden in 2022. The company has simultaneously launched the Nwassa Marketplace Platform, which aims to provide smallholder farmers and agricultural cooperatives with access to a select group of trusted partners which can help with packaging, warehousing, and dry and wet cargo logistics, as well as up-to-date information from the global agricultural sector. Now, the platform processes over 500,000 daily transactions with a value of over $8 million per day; meanwhile, the Tingo Inc posted $593 million in revenues in 2020 with EBITDA totalling $212 million. In a world where growing socio-economic differences and global climate change have challenged sustainable agricultural production and food security, Tingo has aimed to provide an opportunity for Africa to be a core focal point to solve several key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name but a few. For more information, visit the company’s website at www.TingoGroup.com. NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

• Playgon’s management team has three decades of iGaming experience and successful prior exits
• The company’s business is global, with a mobile-first strategy
• Playgon’s proprietary software assets are IP-protected
• The company’s portrait-mode UX is uniquely designed for one-handed play on mobile phones
• Playgon’s position is protected by high barriers to entry in a rapid-growth industry
• Online casinos and sports betting sites/apps are increasingly adding market share to traditional location-based casinos
• The online gambling market is forecast to grow at a CAGR of 12.3%
• The global online gambling market is slated to reach a value of $127.3 billion by 2027, according to Grand View Research, with much of the growth expected from the U.S. and Asia
• The U.S. online gambling market is on pace to reach a value of $19.3 billion by 2025, according to JP Morgan, as the market continues to regulate at a rapid pace

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) is a SaaS technology company focused on developing and licensing digital content for the growing global iGaming market. The company provides a multi-tenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table Games and Daily Fantasy Sports. Seamless integration at the operator level allows customer access without requiring the sharing of any sensitive customer data. Playgon games run on any browser and any device as fast and secure as a native app, without requiring any app store download. All that’s needed is a stable internet connection. The gaming experience is identical across all mobile devices. As a true business-to-business digital content provider, the company’s products are scalable turnkey solutions for online casinos, sportsbook operators, location-based operators, media groups, and big database companies. Playgon’s proprietary technology provides digital games for online gambling sites and mobile device apps, with the company licensing its mobile live-dealer technology to online gaming operators worldwide. Playgon combines high definition live streaming dealers with state-of-the-art augmented reality betting to provide the most authentic casino experience, live from Las Vegas. Playgon’s mobile platform features popular table games, all optimized for one-handed play on mobile devices. The COVID-19 pandemic has accelerated an already existing shift away from location-based casinos to online gambling. At the same time, the proliferation of mobile devices has provided players with new access to betting. A younger, tech-savvy consumer demographic is driving adoption of digital gaming globally. To meet this demand, Playgon has launched a studio with 10 gaming tables from which its live dealer streaming video originates. The company’s platform is live with multiple online casino operators through four aggregator clients in South Africa and Europe, and commitments are coming in from more. Playgon plans to expand the studio to 25 tables in the near term and is working to establish a U.S. strategy. The company will continue to expand licensing of its live dealer games to iGaming operators worldwide under a SaaS license agreement. As a B2B software supplier, Playgon avoids player acquisition costs. Games Live Dealer Casino Playgon offers the first and only Live Dealer Casino streaming live from Las Vegas. The company brings cutting-edge handheld features and functionality to the mobile generation of gaming enthusiasts who demand a world-class gaming experience on all devices. Playgon’s Blackjack delivers the look and feel of location-based casino tables with features providing players with the most unique user experience. The company’s true-to-life Roulette offers players a clear and uninterrupted view of the dealer, wheel, ball, bets, results, trends and statistics. Players can strategize, place multiple bets, track results and review trends without ever losing focus of the game. Playgon’s traditional Baccarat and proprietary Tiger Bonus Baccarat™ prove their worth by not only recognizing the need for a prominent product, but by adding elements which separate them from the pack without removing their authenticity. The games mix advances in technology with the traditional game attributes that have resonated and captivated players for hundreds of years. eTable Games To lead the rise of mobile-first gaming, Playgon developed a user experience perfected for one-handed play. Providing this next evolution in gaming technology ensures the company’s client operators loyalty from existing customers and is a powerful strategy to attract and retain new players. Playgon’s VEGAS LOUNGE(TM) brings together an innovative mix of games, technology and gameplay that offers players an authentic experience and real Las Vegas casino fun every time, everywhere. Daily Fantasy Sports Playgon’s Daily Fantasy Sports (“DFS”) are a subset of fantasy sport games which typically target a younger demographic. DFS provides iGaming operators a turnkey fantasy sports platform that can quickly go to market, integrate with the operator’s existing operations and services, and be customized to match and enhance the operator’s brand. The platform is mobile and desktop friendly, built for regulated market environments, and allows operators to monetize users through a network of shared liquidity. Market Outlook Online casinos and sports betting sites/apps are increasingly adding market share to traditional location-based casinos. This trend is only expected to accelerate as millennials reach their peak earning years and Gen Z youth begin to complete their education and move into careers. These generations are completely comfortable with online recreation, as well as tech like digital wallets and digital gameplay that underpins Playgon Games. The company has been described as “Netflix + Vegas, all in one.” The online gambling market is slated to reach a value of $127.3 billion by 2027, according to Grand View Research, with much of the growth expected from the U.S. and Asia. Even Europe, the most mature gaming market, is expected to grow at a rate of 20-25 percent year over year. The current global online Live Casino TAM is estimated at about $6 billion annually, and revenue is forecast to reach more than $8 billion by 2023 and more than $13 billion by 2027. Management Team Darcy Krogh is CEO of Playgon Games. He is a veteran of the iGaming industry with over 20 years of experience. In 1999, he co-founded Chartwell Technology Inc., which pioneered the development of browser-based digital content for the iGaming industry. After that company was sold to Amaya Gaming Group, he served as VP Business Development with Amaya. In 2016, he started Playgon Games (formally Global Daily Fantasy Sports Inc.) as President and CEO. His experience in the online gaming industry includes sales and marketing, relationship management, corporate finance, M&A, and strategic corporate development. Guido Ganschow is President of Playgon Interactive. He has more than 12 years of experience in creating real-time Live Dealer technology and platforms and was the co-founder and Creative Director for a Macau-based casino consortium. Between 2008 and 2014, he successfully created and established Live Dealer platform businesses in Asia and Europe, and executed commercial partnerships, sales, and integration of the Live Dealer solution with major global gaming brands, including Ho Gaming Group, Chartwell Technology and Amaya Gaming Group. Steve Baker is COO of Playgon. He is a former VP Operations for Shaw Communications, where he was directly involved in video streaming, home entertainment, new products, sales and M&A. He oversaw revenue growth from $300 million to $2.8 billion and employee growth from 350 to 13,000. He has broad experience and a proven record in development and implementation of cost effective and efficient growth strategies transitioning businesses from development to operations. Harry Nijjar is CFO of Playgon Games. He is currently a Managing Director with Malaspina Consultants Inc. and provides CFO and strategic financial advisory services to his clients across many industries. This experience has allowed him to help his clients successfully navigate the regulatory and financial environments within which they operate. Mr. Nijjar holds a CPA-CMA designation from the Chartered Professional Accountants of British Columbia. For more information, visit the company’s website at www.Playgon.com. NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

• INND purchased all assets and operations of iHEAR Medical, a venture-backed provider of FDA-cleared cloud-based hearing solutions
• Acquisition provides INDD access to over 40 patents developed by acquired company and opportunity to expand market reach by leveraging its distribution channels
• INND appears poised to position itself as leader in DTC hearing space; expects acquisition to rapidly expand Company’s sales and distribution capabilities

InnerScope Hearing Technologies (OTC: INND), a leading manufacturer and distributor of FDA-registered hearing products and Personal Sound Amplifier Products, has acquired all assets and operations of iHEAR Medical Inc. (“iHEAR”), a venture-backed pioneer in the online direct-to-consumer hearing solutions. InnerScope expects the acquisition to expand and solidify the Company’s position as the emerging leader in the market of direct-to-consumer and over-the-counter hearing products. Acquired assets include iHEAR’s FDA-Registered manufacturing facility, R&D center, and shipping operations in San Leandro, California (https://ibn.fm/3oM09). The California-based iHEAR has a demonstrated track record in bringing novel hearing solutions to the market. It boasts a team that holds more than 100 patents in miniature hearing electronics and medical devices. Often featured in major media outlets such as CNN, New York Times, Dr. Oz Show, USA Today and Inc. Magazine, iHEAR’s founders developed innovations that went on to receive significant recognition, including the Medical Device Excellence Award (https://ibn.fm/tJ7Ev). With a shared vision and mission to address the global demand for affordable hearing solutions, the two companies have compatible business models that can help InnerScope position itself as a leader in the direct-to-consumer hearing products market. In the words of Matthew Moore, President, and CEO of InnerScope, the transaction will allow InnerScope to unlock synergies and leverage this unparalleled access to cutting-edge innovation in the hearing products space. “The Acquisition of iHEAR Medical brings world-class innovation and access to over 40 patents in hearing technology,” he said. “Our alliance with iHEAR and its technology partners allow us to rapidly expand sales and distribution, particularly through pharmacies and insurance partners.” Through this acquisition, InnerScope will be able to broaden its product offering to include the only FDA-cleared home hearing screener, iHEARtest(TM), (FDA clears home hearing test) advanced FDA-registered hearing aids, and the TReO(TM) Personal Sound Amplification Product (“PSAP”). The transaction will also enable InnerScope to expand its market reach and leverage iHEAR’s established distribution channels to gain access to partners in retail and wholesale space as well as in insurance and direct online sales. Retail and wholesale partners include names such as CVS Pharmacy, Cardinal Health, AmerisourceBergen, Western States Pharmacy Coalition (“WSPC”), Good Neighbor Pharmacy, FSA Store and Amazon, while insurance partners include insurers such as VIA Benefits, Ameritas and Willis Towers Watson. In addition, the full range of iHEAR-branded products will remain available online at http://iheardirect.com. Following the acquisition, InnerScope has ambitious plans for the future. “Leveraging the renowned R&D talents of iHEAR Medical, InnerScope plans to develop next-generation hearing products incorporating artificial intelligence (“AI”), advanced sound processing for improved hearing in noise environments, and seamless wireless connectivity to Internet-Of-Things (“IoT”) devices,” stated Moore. Hearing loss affects around 5% of the global population, the vast majority of which remains untreated due to prohibitive barriers, such as high cost, complex dispensing processes, and lack of access to high-quality hearing products. But left untreated, hearing loss can be associated with a range of social, economic, and health problems. As a leading manufacturer and distributor of FDA-registered hearing products and Personal Sound Amplifier Products (“PSAPs”), InnerScope is dedicated to addressing the global demand for affordable hearing solutions. With the acquisition of iHEAR Medical, InnerScope appears well-positioned further to expand its leadership in the direct-to-consumer hearing solutions market. InnerScope launched its hearing aids on FSAstore.com, HSAstore.com, and WellDeservedHealth.com to consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HSA”), and employers’ health incentive programs. For more information, visit the company’s website at www.INND.com and the company’s e-commerce website: www.MyHearIQ.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• Blood and genomic testing are becoming preferable means of early cancer screening and detection
• Leaders innovating this niche of the medical industry include AnPac Bio, Grail, Thrive and Guardant
• AnPac Bio-Medical’s testing features a database of more than 200,000 commercial and research multi-cancer test samples (probably the largest multi-cancer test data base) that detect up to 26 different types of cancer
• One of the few companies offering multi-cancer tests for risk assessment and actually contributing to the fight against cancer by having its high risk individuals (tested first by its tests and later) confirmed in the healthcare providers for cancer patients and pre-cancer patients early

Almost 1.9 million new cancer cases will be diagnosed in the United States in 2021, according to American Cancer Society (“ACS”) estimates. This number excludes basal cell, squamous cell skin cancer, and carcinoma in situ except for urinary bladder cancer. The ACS also estimates that the number of Americans to die from cancer in 2021 will be 608,570, equivalent to 1,670 people per day (https://ibn.fm/qcO5q). To address these rising cancer rates, biotechnology companies in the U.S. and worldwide are focusing on the early detection and screening of cancer through the development of proprietary technologies. AnPac Bio-Medical Science The companies currently paving the way for early cancer screening and detection include AnPac Bio-Medical Science (NASDAQ: ANPC), Illumina, Inc.’s (NASDAQ: ILMN), Grail, Inc. (now part of Illumina), Exact Sciences Co., Ltd. (NASDAQ: EXAS), and Thrive Earlier Detection (now part of Exact Sciences), and Guardant Health (NASDAQ: GH). All four of these companies have developed blood and genomic tests that help detect and screen for early cancers, some of which have no other means of early detection. Powered by a database containing over 200,000 samples and cases, AnPac Bio’s Cancer Differentiation Analysis (“CDA”) is a proprietary novel technology for early cancer screening and detection. CDA technology can detect and carry multi-level information including cellular and protein level information to determine the existence of cancerous environments. At present, our CDA platform can detect up to 26 different types of cancer, which gives AnPac Bio a major advantage over industry peers in terms of cost effectiveness, multi-cancer testing, ability to detect cancer early with high sensitivity and specificity. With its proprietary technology and being one of the first companies in the world to introduce the concept of multi-level, multi-parameter and multi-cancer (pan-cancer) screening approaches, AnPac Bio is uniquely positioned to be a leader among other prominent cancer screening and detection blood testing companies currently on the market. The company has accredited clinical laboratories in the U.S. and China, and a total of 142 patents issued since the early 2010s, a significantly higher number of patents as compared to its industry peers (Grail has 80 patents https://ibn.fm/iQ09Q and Thrive has 1 filed patent https://ibn.fm/LOBXP). In 2019, a Frost & Sullivan report ranked AnPac Bio third in the world and first in China among those companies that offer next-generation early cancer screening and detection testing in terms of the number of clinical samples. Other Companies Thrive’s CancerSeek is a liquid biopsy blood test for the detection of cancer at its early stages. The results were published in a 2020 issue of Science, demonstrating that the blood test more than doubled the number of detected cancers, with 65% of these samples were at earlier stages, across ten cancer types, with seven of them having no recommended standard-of-care tests. Guardant Health reported recently at ASCO 2021 that its Lunar-2 colorectal cancer screening study achieved overall sensitivity of 91% in early-stage CRC detection (stage I, II, and III), and specificity of 94%. The ECLIPSE study will screen for colorectal cancer where they plan to enroll 10,000 people between the ages of 60-84 from across the United States by the end of 2021. Galleri(TM) is GRAIL’s trademarked cancer screening and detection blood test. This blood test can detect over 50 types of cancer, allowing patients to take control of their health and be proactive about cancer screening. This blood test is recommended for people ages 50 and older and is intended to be used in addition to other cancer screening tools recommended by a primary healthcare provider. Liquid biopsy-based noninvasive testing is leading the way for early cancer screening, detection and diagnosis, often preferable to other cancer testing methods. With an increase in cancer cases globally, early detection and screening is becoming prevalent across much of the healthcare industry. Worldwide, the cancer diagnostics market is expected to grow at a CAGR of 7% during the forecast period, resulting in a market value of $249.6 billion by 2026 (https://ibn.fm/aANDy). For more information, visit the company’s website at www.AnPacBio.com. NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

• Delic Holdings Corp. (the “company” or “Delic”) reported Q2 revenues of $149,290 while realizing a strong gross profit margin of 87%
• The company has recently broadened its business verticals through the acquisition of Homestead, a psychedelic media distributor, and Ketamine Infusion Centers LLC, one of the largest chains of ketamine clinics in the U.S.

Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leading psychedelic wellness platform committed to bringing science-backed benefits to its many stakeholders, has recently published its second quarter results for the 2021 fiscal year. The company reported Q2 revenues of $149,290. Delic also reported second quarter gross profits of $130,129, resulting in an impressive 87% gross profit margin (https://ibn.fm/DZ5QQ). The company owns and operates a self-sustaining ecosystem of businesses in the psychedelic space consisting of media, science and health business verticals. Delic has been particularly active on the mergers and acquisition front over the last several months in a bid to further broaden the company’s business horizons. On June 30, 2021, the company acquired Ketamine Infusion Centers LLC (“KIC”), one of the largest ketamine clinics in the United States, for gross consideration of $3,040,312. In March, Delic successfully completed the acquisition of the brand and intellectual property of Homestead, a legacy counterculture distributor of psychedelic media and creator of one of the first self-contained mushroom grow kits. Moving forward, the Delic ecosystem will be centered across three primary pillars, namely — media, health and science. On the media front, the company will seek to nurture new audiences and educate the public on the latest developments within the psychedelic sector through a variety of digital platforms, including Delic’s Reality Sandwich digital magazine; Meet Delic, the first-ever psychedelic wellness summit to be based in Las Vegas and which attracted over 2,000 live attendees at its inaugural event; and Delic Radio, an online podcast program boasting over 43 episodes and upwards of 100 thousand total streams to date. Delic’s focus within the health sphere will be centered around the Ketamine Infusion Centers, an Arizona-based clinical chain with three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. The clinics, which have cumulatively overseen 4,000+ treatments delivered to date, have plans to scale and operate over 20 clinics, with a plan to operate 10 more clinics over the coming 18 months. On its Sept. 20 press release, Delic announced a merger with Arizona-based ketamine infusion clinic company Ketamine Wellness Centers Inc. KWC operates 10 clinics across multiple states, cementing Delic’s position as the largest ketamine health provider and psychedelic wellness chain in the country. “The Delic team is committed to making psychedelic wellness accessible to the masses, and with this chain of clinics and upcoming acquisitions, we are making that vision possible,” stated Matt Stang, Founder and CEO (https://ibn.fm/GIz2h). Lastly, the company’s science business will be focused around developing IP and advanced extraction and testing facilities, which form the backbone of the legal market. The company will center their efforts through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver and the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology. North America is currently blazing the path in advancing the psychedelic industry through a variety of forward-looking research projects, at a time when psychedelics are increasingly becoming accepted globally on the basis of their therapeutic, medical, and recreational use. With 32 million people in the U.S., or 17% of all American adults aged 21 to 64, having used psychedelics at least once, the industry seems to be well on its way to mainstream acceptance (https://ibn.fm/7K7YX). Through their various initiatives and three core business verticals, Delic Corp. is well positioned to capitalize on the sector’s continued growth trajectory. For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• StraightUp Resources’ mission is to maximize shareholder wealth and value through mineral discoveries at projects with carefully analyzed potential, focused on the acquisition, development, and exploration of mineral resource properties in North America
• The company completed an IPO in March 2020 and has since acquired six properties in Canada and the United States (RLX NORTH, RLX SOUTH, BELANGER, FERDINAND, BEAR HEAD, WEST CAT MINE).
• Its Canadian properties are located in an area with a rich mining history and currently revealing a resurgence of gold-bearing deposits that were overlooked in the past
• Together with the recent acquisition of property in Nevada, StraightUp is positioning itself among companies of significant potential within this sector

StraightUp Resources (CSE: ST) is on a mission to maximize shareholder value and wealth through mineral discoveries at projects with robust potential, maintaining long-lasting partnerships, and continued focus on the acquisition, development, and exploration of mineral resource properties in North America. Since completing an initial public offering (“IPO”) in March last year and a non-brokered private placement a month later, the Sechelt, British Columbia-headquartered company embarked on a journey that has seen it acquire mining assets and conduct magnetic surveys and field examinations. The first in the series of acquisitions was the June 11, 2020 announcement that it had been granted the exclusive right and option to acquire certain unpatented mining claims comprising RLX North, RLX South, and Belanger Red Lake gold properties (https://ibn.fm/07JU2). Upon receiving exploration permits for the properties shortly thereafter, the company repatriated, re-logged, and assayed – compiled and reinterpreted – all available historical data for the Belanger property and subsequently announced results in February this year (https://ibn.fm/FbV4Y). In addition, a 43-101 Technical Report was also completed on the Belanger Property in June of this year. For its RLX North and RLX South assets (“RLX properties”), StraightUp Resources acquired a digital database of compilation and field exploration data for the properties in November 2020. The company then commenced the ground magnetic (“MAG”) survey in March this year and the Heli-borne MAG survey a few months later in July. With the latter MAG survey already complete, the company expects a final report early this month. “These projects are in the heart of the Red Lake Mining District, an area that is seeing a resurgence of gold-bearing deposits that were overlooked in the past,” commented StraightUp President and CEO Mark Brezer, following the completion of the Heli-borne MAG survey (https://ibn.fm/B2O97). “RLX North and South almost completely surround Great Bear Resources Sobel Project, and with our accumulated data from the region and upcoming MAG results, we can better pinpoint future drill programs.” This year also witnessed the second addition to StraightUp’s growing asset portfolio, when, in March, it acquired the Ferdinand Gold Property in Ontario. The property, situated near Red Lake, consists of 17 claims comprising 354 cells and encompassing 6,600 hectares. According to the press release detailing the terms of the acquisition, the Ferdinand Gold Property is situated within the prolific Uchi Subprovince, one of the most metal endowed greenstone belts in the world by square kilometer (https://ibn.fm/QcTwm). StraightUp, which in June initiated and received preliminary results on a high-resolution Heli-borne MAG survey on the Ferdinand Gold Property, has since started ground exploration. In describing this crucial milestone, Brezer noted that the exploration marks entry into an area that has been largely unexplored. “The Ferdinand Gold Project is within a crucial scale deformation zone that has never seen a drill hole. Results from our recent Heli-borne MAG survey have identified high priority targets and important geological structures for crews to begin prospecting, sampling, and mapping,” Brezer continued (https://ibn.fm/9lpBa). In July, StraightUp acquired the Bear Head Gold Property comprising 31 mining claims totaling 1,944 hectares in the Meen-Dempster Greenstone Belt, which hosts the Golden Patricia former gold mine that produced 620,000 ounces of gold at an average grade of 15.2 g/t from 1988-1997. According to Brezer, this acquisition complements the Ferdinand Gold Property. Last month, the company acquired the historic West Cat Mine in Nevada, US, marking its expansion into new mining districts as it continues to position itself among top-quality assets and companies. Through its focus on strategic acquisitions and exploration work, StraightUp Resources is making an indelible mark on the mining scene all the while maximizing shareholder wealth and value. For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to ST are available in the company’s newsroom at https://ibn.fm/STR

• Palliative care focuses on providing end-of-life care for chronically ill patients
• Preliminary research suggests cannabis relieves pain, appetite loss, anxiety
• RYAH is the leader in volume-control technology for plant-based medicine
• RYAH’s ecosystem includes volume-control devices, medicine-carrying components, and AI-powered applications that capture and track data

With a mission to advance remote-health solutions and analytics-based patient treatments across the world, RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, is positioned to address the urgent need for cannabis-based solutions in palliative care. Palliative care is an emerging healthcare field that focuses on providing solutions that alleviate the suffering of patients with a chronic diagnosis, including cardiovascular disease, cancer, chronic respiratory disease, AIDS, and diabetes. While end-of-life care is not a curative approach, treatments provided to patients focus on improving quality of life and relieving symptoms such as pain, depression, anxiety, and appetite loss. The World Health Organization (“WHO”) states that only 14 percent of approximately 40 million people that need end-of-life care each year receive it (https://ibn.fm/Nt4zU). A growing body of research demonstrates that cannabis and cannabinoids help ease symptoms associated with many chronic diseases (https://ibn.fm/tJFnF). While the research is still ongoing, cannabis continues to be a physician-recommended option to alleviate suffering by relieving symptoms such as pain, anxiety, and loss of appetite. Accordingly, evidence suggests that cannabis can replace opioids or be used as a suitable cotreatment to reduce opioid load (https://ibn.fm/AzgTk), with 67 percent of oncologists reporting that medical cannabis was a helpful treatment in conjunction with standard pain management approaches (https://ibn.fm/67QXG). RYAH’s ecosystem of IoT products, including its volume-control devices, medicine-carrying components, and mobile applications, can provide a reliable way for researchers and clinicians to develop well-controlled environments to study the use of cannabis for palliative care. Accordingly, the company’s Smart Dry-Herb Dose-Measuring Inhaler is currently being used in one of the most extensive medical studies ever undertaken. Other devices to follow include a Smart Transdermal Patch in the production stage and a Smart Liquid Dispensing Pen in the prototype stage. The development of RYAH’s Data Ecosystem is part of the company’s goal of generating AI-powered models that can provide precision treatments for various diseases, including chronic conditions requiring end-of-life care. Along with delivering volume-controlled devices, RYAH’s technology stack includes QR tracking applications to track product formulations and dosing parameters, as well as mobile applications that can manage volumetric data and provide patient feedback. RYAH is dedicated to helping doctors and patients unlock the power of data to provide better patient outcomes. With its robust intellectual property portfolio, AI-powered technology, and suite of portable, cost-effective products, the company is positioned to capitalize on growth opportunities in the IoT and data intelligence sectors while providing critical volume-control solutions for the plant-based medical industry. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

• USA CBD Expo will host their upcoming October conference at Chicago’s McCormick Place between October 28-30, 2021.
• Forming part of the nation’s largest CBD event series, the USA CBD Expo will cater to CBD industry newcomers and seasoned industry professionals alike
• The conference will play feature a series of keynote presentations and discussions delivered by some of the industry’s leading thinkers and innovators
• In addition, the Expo will also be host to over 500 of the industry’s largest and most pioneering brands who will showcase their diverse product ranges under a single roof

USA CBD Expo is set to host their upcoming conference in conjunction with presenting sponsor, 3Chi, the nation’s largest CBN and Delta-8 distributor, at Chicago’s McCormick Place on October 28-30, 2021. The event will mark a new iteration of the nation’s largest CBD event series, which will provide conference attendees with the unique opportunity to hear from over 50 expert speakers, visit hundreds of vendors, and network alongside thousands of their peers. The USA CBD Expo has long established a well-earned reputation as the United States’ largest dedicated CBD conference series, bringing together the entire CBD and Hemp industry within a single, comprehensive, and all-inclusive event. Having originally started with an exclusive focus on the global vaping community, the USA CBD Expo has expanded over the past several years, culminating in a series of all-encompassing, premier trade shows which seeks to provide delegates with a fun, thrilling experience that promotes business networking within the industry. The upcoming Expo, which has been designed to cater to CBD industry newcomers and seasoned industry professionals alike, will seek to introduce attendees to a carefully curated group of CEO’s, corporate leaders, and sector thought leaders who will delve deeper into the intricacies surrounding the industry through a series of educational seminars, keynote addresses, and workshops. Industry personalities in attendance at the conference will include the likes of Samm Macias and Nick Smeriglio, Angela Ardolino of CBD Dog Health; Asa Waldstein from the Supplement Advisory Group; Angela Boyce of Primo Gardens; and Jason Gann, star of Wilfred and representing Wilfred CBD, among a variety of other featured speakers. Seminars will focus on a wide array of topics, including providing attendees with an overview of changes within the commercial side of the CBD and hemp industry, current and future CBD market trends, health benefits, ongoing legalization efforts as well as medicinal use cases. Additionally, some of the scheduled talks include CBD for sexual wellness, psychedelics education, the power of medicinal mushroom extracts, information about delta-8 and its legality, among other diverse topics. In addition to its standout list of industry personalities and expert speakers, the USA CBD Expo will also bring together upwards of 500 of the industry’s largest and most pioneering brands under a single roof. Participants can explore and discover some of the CBD and hemp sector’s newest and most innovative products, ranging from edibles and beverages to cosmetics and pet products. Additional information about the USA CBD Expo, as well as details for registration, can be found at the USA CBD Expo website at https://usacbdexpo.com/

Date: October 29, 2021 Online Virtual Event Bitcoin Events is proud to announce the third edition of Crypto Fest, scheduled for October 29, 2021. This one-day online event will feature controversial speakers and discussions with a focus on Non-Fungible Tokens (“NFTs”) and Decentralized Finance (“DeFi”). This year’s event targets fintech professionals, cryptocurrency mining entities, retail and institutional investors, and crypto and NFT enthusiasts. It guarantees a jam-packed day with exciting keynotes, presentations, workshops, product exhibitions, competitions, entertainment and contentious topics that are specifically geared towards offering attendees value and the requisite knowledge to navigate through the crypto world. Over 2,500 attendees are expected to show up for the event. Additionally, over 30 global innovators and thought leaders in the blockchain and cryptocurrency industry will take the stage to discuss different topics and even engage in debates amongst each other. There will also be a Q&A session where the event’s speakers will answer attendees’ questions. Crypto Fest 2021 promises a great networking opportunity with some of the industry’s most progressive professionals across different industries including, but not limited to mining, trading, insurance, finance, software infrastructure, regulation, legal, auditing and investment, among others. The audience will learn everything about the different tools, techniques, and platforms available for effective crypto investment and trading, especially with the ongoing proliferation of alternative currencies. Through this event, attendees will discover how cryptocurrencies can enable financial inclusion and greater participation in the financial ecosystem. They will also understand the consumer demands of the future and learn how to develop strategies for successful cryptocurrency and blockchain implementation. The audience will explore different collaborations and even create new strategic partnerships at the available exhibition booths. The audiences’ chance to win prizes and giveaways from the event’s sponsors and partners is even more exciting. There will also be an after-party right after the main event where attendees will enjoy some music and interact even further with their colleagues and partners in the industry. Crypto Fest 2019 and 2020 were both successful in attendance and pushing the conversation around alternative currencies and blockchain. Bitcoin Events has made a name for itself as Africa’s leading blockchain and cryptocurrency event organizer since its inception in 2014. As such, Crypto Fest 2021 pledges to build on all the previous events and to take things a notch higher, creating more engagement and offering a platform through which individuals in the crypto and blockchain space can interact, learn and grow. This event guarantees value to attendees. With a lineup of world-class global speakers and specially-curated topics, attendees are guaranteed to leave with knowledge, contacts and ideas that will take their businesses to the next level. This has always been the goal with Crypto Fest, and this 2021 event promises to be no different.

• For those who want to be part of the virtual event, please register here for free (https://ibn.fm/5W1ac)
• Should you wish to exhibit at the event, visit our page here (https://ibn.fm/73PCQ)
• If you would like to become a speaker at the event, please submit your application here (https://ibn.fm/IPDxb)
• To sponsor the event, please visit (https://ibn.fm/whI98)

• Date: Nov. 8-9, 2021
• Venue: Adrienne Arsht Center for the Performing Arts, Miami
• Agenda: Two days of expert panels covering a variety of topics surrounding the psychedelics industry’s medicinal, corporate and regulatory impact and beyond
• Tickets and Registration Info: Visit https://microdose.buzz/wonderland/miami/

As the health and wellness industry evolves, a veritable flood of innovators searching for the next frontier in holistic product market opportunities has turned recently to the potential of entheogenic (psychedelic) substances long taboo under the umbrella of war-on-drugs regulations. In September, news that the federal government’s National Institute on Drug Abuse (“NIDA”) is providing a funding grant for a study into how psilocybin could help people quit smoking cigarettes showed the potential strength of the psychedelics reform movement (https://ibn.fm/gRbUg). Conference event series organizer Microdose’s Wonderland: Miami gathering promises to be the largest psychedelic medicine business event ever when it opens its doors Nov. 8-9 in Miami’s Adrienne Arsht Center for the Performing Arts, one of the largest performing arts centers in the United States (https://ibn.fm/L73Vg). During two days of panels covering subjects that range from the current state of regulatory acceptance of psychedelics and their uses to next-generation research and development, dozens of innovators and experts in the industry will address leading concerns for anyone interested in the sector. Former world heavyweight champion boxer Mike Tyson and two-time NBA Champion basketball player Lamar Odom will provide athletic celebrity to the event, with Tyson addressing neurological health and wellness and Odom talking on ketamine’s future possibilities. Microdose sponsors monthly events designed to promote the psychedelics industry and awareness of its financial potential. The company’s newsletter provides a continuous feed of news and updates on the industry’s businesses and marketplaces, merchandise and educational opportunities. The Wonderland event organizers have partnered with internationally award-winning design teams to make the in-person event unforgettable, using projection mapping technology to create an animated, living stage. A first set of annual awards, a competition to pitch to venture capitalists and the opportunity to obtain a need-based scholarship to Wonderland provide extra depth to the experience. Microdose anticipates an audience spanning more than 140 countries to experience the insights offered by panelists bookended by the University of California, San Francisco and Baltimore, Maryland’s Johns Hopkins University School of Medicine, with a wide array of corporate and non-profit interests on display. A second round of early-bird tickets are still available, as well as standard, business entry and VIP pricing. A virtual access pass is also available for participants who prefer to attend via the event’s livestream or review sessions that they may have initially missed. For further information on the November conference and to obtain tickets for the event, visit https://microdose.buzz/wonderland/miami/.